Oncology Pharma Competitors and Similar CompaniesClear all

Oncology Pharma's competitors and similar companies include Karo Healthcare, Rakuten Medical, Xilio Therapeutics and BioAtla.

	Oncology Pharma Oncology Pharma (formerly known as SourcingLink.net) is an oncology company dedicated to licensing, developing, manufacturing, and commercializing therapeutics.	Karo Healthcare Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.	Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.	Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.	BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
Founding Date	Founding Date 1993	Founding Date 1987	Founding Date 2013	Founding Date 2015	Founding Date 2007
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations San Francisco, US HQ	Locations Stockholm, SE HQ Stockholm, SE	Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US	Locations Waltham, US HQ	Locations San Diego, US HQ
Employees	Employees N/A	Employees 225	Employees 1241% increase	Employees 69	Employees 616% decrease
Valuation ($)	Valuation ($) 3.8 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 43.5 m	Valuation ($) 100.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) kr3b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $43.8m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income (kr17m) (FY, 2021)	Net income N/A	Net income ($35m) (FY, 2025)	Net income ($59.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 451.9m	Total funding raised $ 233m	Total funding raised $ 186.5m